Dr. rer. nat. Simon Völkl

Department of Medicine 5 – Haematology and Oncology

Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience (2020) Brandt A, Vasova I, Winkler J, Mackensen A, Rösler W, Spoerl S, Völkl S Conference contribution Profiling extracellular vesicles (EV) in patients with acute GvHD after allogeneic stem cell transplantation (2020) Böttcher M, Stoll A, Böttcher-Loschinski R, Rösler W, Winkler J, Mackensen A, Mougiakakos D, et al. Conference contribution CD19 CAR-T cell treatment of CNS relapse of Burkitt's lymphoma: A case report (2020) Aigner M, Jacobs B, Gary R, Kretschmann S, Achenbach S, Mackensen A, Mougiakakos D, et al. Conference contribution Impact of Nrf2 expression in reconstituting T-cells of allogeneic hematopoietic stem cell transplanted patients (2020) Karl F, Stoll A, Gamali S, Böttcher-Loschinski R, Böttcher M, Baur R, Jacobs B, et al. Conference contribution Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling (2020) Tohumeken S, Böttcher M, Stoll A, Loschinski R, Panagiotidis K, Braun M, Saul D, et al. Journal article A novel interaction between hydrogen peroxide metabolism and LDL-uptake controls immunergulatory properties in human dendritic cells - Potential implications for tumor immune escape (2020) Menzner AK, Rottmar T, Bosch JJ, Mougiakakos D, Mackensen A, Resheq Y, Völkl S Conference contribution Vascular occlusion by neutrophil extracellular traps in COVID-19 (2020) Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, Stürzl M, et al. Journal article Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA (2020) Strobl C, Schaffer S, Völkl S, Haug T, Peter K, Singer K, Böttcher M, et al. Journal article Impact of Nrf2 expression in reconstituting T-cells of allogeneic hematopoietic stem cell transplanted patients (2020) Karl F, Stoll A, Böttcher-Loschinski R, Böttcher M, Jacobs B, Jitschin R, Rösler W, et al. Journal article Mechanistic Characterization of Tafasitamab-Mediated Antibody-Dependent Cellular Phagocytosis Alone or in Combination with Lenalidomide (2019) Mougiakakos D, Völkl S, Bach C, Stoll A, Bitterer K, Beier F, Endell J, et al. Conference contribution